PUBLISHER: KBV Research | PRODUCT CODE: 1093029
PUBLISHER: KBV Research | PRODUCT CODE: 1093029
LAMEA Renal Denervation Market Size, Share & Industry Trends Analysis Report By Technology (Radiofrequency, Ultrasound, and Micro-Infusion), By End User, By Product Type By Country and Growth Forecast, 2022 - 2028
The Latin America, Middle East and Africa Renal Denervation Market would witness market growth of 42.0% CAGR during the forecast period (2022-2028).
Resistance hypertension requires four or more antihypertensive medicines to maintain blood pressure below 130/80 mmHg. RH is a rapidly increasing clinical disease that is linked to target-organ damage and a poor prognosis when compared to non-RH patients. Renal denervation therapy for RH had a complex history over the few years, ranging from exuberant enthusiasm to abrupt disillusionment, and now a renewed but cautious interest. Major market players are analyzing typical clinical trials of RH addressed with RDN in previous years and determined that RDN therapy appears to be safer and more dependable for RH. Moreover, the potential functions of RDN are still being reviewed in clinical practices and appear to have validated the benefits of RDN on long-term results in RH patients. Resistant hypertension is characterized as high blood pressure despite using at least three antihypertensive drugs from various classes, one of which is a diuretic.
As per the data shared by the Abu Dhabi's Department of Health, cardiovascular disease is the top cause of mortality among Abu Dhabi's population. This has not improved over time, despite the enormous commitment of time and resources. Over 39 percent of deaths in people over 45 years old were due to cardiovascular disease. CVD kills more people over the age of 60 than cancer, respiratory disorders, and infectious diseases combined. A poor diet is the major cause of CVD mortality, with one study estimating that the current diet was responsible for 72 percent of CVD deaths in the United Arab Emirates. In the United Arab Emirates, low consumption of whole grains was linked to 22% of CVD-related deaths. Consumption of red meat, processed meat, and sugar-sweetened beverages are further risk factors.
The Brazil market dominated the LAMEA Renal Denervation Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $25.6 million by 2028. The Argentina market is estimated to grow a CAGR of 42.8% during (2022 - 2028). Additionally, The UAE market would exhibit a CAGR of 41.7% during (2022 - 2028).
Based on Technology, the market is segmented into Radiofrequency, Ultrasound, and Micro-Infusion. Based on End User, the market is segmented into Hospitals, Specialty Clinics, and Others. Based on Product Type, the market is segmented into Symplicity, Enlightn, Vessix, Paradise, Iberis, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Ablative Solutions, Inc., Mercator MedSystems, Inc., ReCor Medical, Inc., Renal Dynamics Limited, Johnson & Johnson, and Terumo Corporation.
Scope of the Study
Market Segments covered in the Report:
By Technology
- Radiofrequency
- Ultrasound
- Micro-Infusion
By End User
- Hospitals
- Specialty Clinics
- Others
By Product Type
- Symplicity
- Enlightn
- Vessix
- Paradise
- Iberis
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic PLC
- Ablative Solutions, Inc.
- Mercator MedSystems, Inc.
- ReCor Medical, Inc.
- Renal Dynamics Limited
- Johnson & Johnson
- Terumo Corporation
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA Renal Denervation Market, by Technology
- 1.4.2 LAMEA Renal Denervation Market, by End User
- 1.4.3 LAMEA Renal Denervation Market, by Product Type
- 1.4.4 LAMEA Renal Denervation Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. LAMEA Renal Denervation Market by Technology
- 3.1 LAMEA Radiofrequency Market by Country
- 3.2 LAMEA Ultrasound Market by Country
- 3.3 LAMEA Micro-Infusion Market by Country
Chapter 4. LAMEA Renal Denervation Market by End User
- 4.1 LAMEA Hospitals Market by Country
- 4.2 LAMEA Specialty Clinics Market by Country
- 4.3 LAMEA Others Market by Country
Chapter 5. LAMEA Renal Denervation Market by Product Type
- 5.1 LAMEA Symplicity Market by Country
- 5.2 LAMEA Enlightn Market by Country
- 5.3 LAMEA Vessix Market by Country
- 5.4 LAMEA Paradise Market by Country
- 5.5 LAMEA Iberis Market by Country
- 5.6 LAMEA Others Market by Country
Chapter 6. LAMEA Renal Denervation Market by Country
- 6.1 Brazil Renal Denervation Market
- 6.1.1 Brazil Renal Denervation Market by Technology
- 6.1.2 Brazil Renal Denervation Market by End User
- 6.1.3 Brazil Renal Denervation Market by Product Type
- 6.2 Argentina Renal Denervation Market
- 6.2.1 Argentina Renal Denervation Market by Technology
- 6.2.2 Argentina Renal Denervation Market by End User
- 6.2.3 Argentina Renal Denervation Market by Product Type
- 6.3 UAE Renal Denervation Market
- 6.3.1 UAE Renal Denervation Market by Technology
- 6.3.2 UAE Renal Denervation Market by End User
- 6.3.3 UAE Renal Denervation Market by Product Type
- 6.4 Saudi Arabia Renal Denervation Market
- 6.4.1 Saudi Arabia Renal Denervation Market by Technology
- 6.4.2 Saudi Arabia Renal Denervation Market by End User
- 6.4.3 Saudi Arabia Renal Denervation Market by Product Type
- 6.5 South Africa Renal Denervation Market
- 6.5.1 South Africa Renal Denervation Market by Technology
- 6.5.2 South Africa Renal Denervation Market by End User
- 6.5.3 South Africa Renal Denervation Market by Product Type
- 6.6 Nigeria Renal Denervation Market
- 6.6.1 Nigeria Renal Denervation Market by Technology
- 6.6.2 Nigeria Renal Denervation Market by End User
- 6.6.3 Nigeria Renal Denervation Market by Product Type
- 6.7 Rest of LAMEA Renal Denervation Market
- 6.7.1 Rest of LAMEA Renal Denervation Market by Technology
- 6.7.2 Rest of LAMEA Renal Denervation Market by End User
- 6.7.3 Rest of LAMEA Renal Denervation Market by Product Type
Chapter 7. Company Profiles
- 7.1 Abbott Laboratories
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.2 Boston Scientific Corporation
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expense
- 7.3 Medtronic PLC
- 7.3.1 Company overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental and Regional Analysis
- 7.3.4 Research & Development Expenses
- 7.3.5 Recent strategies and developments:
- 7.3.5.1 Partnerships, Collaborations, and Agreements:
- 7.4 Ablative Solutions, Inc.
- 7.4.1 Company Overview
- 7.5 Mercator MedSystems, Inc.
- 7.5.1 Company Overview
- 7.6 ReCor Medical, Inc (Otsuka Holdings Co., Ltd.)
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expenses
- 7.6.5 Recent strategies and developments:
- 7.6.5.1 Product Launches and Product Expansions:
- 7.7 Renal Dynamics Limited
- 7.7.1 Company Overview
- 7.8 Johnson & Johnson
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Segmental &Regional Analysis
- 7.8.4 Research & Development Expenses
- 7.8.5 Recent strategies and developments:
- 7.8.5.1 Partnerships, Collaborations and Agreements:
- 7.9 Terumo Corporation
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental Analysis
- 7.9.4 Recent strategies and developments:
- 7.9.4.1 Acquisition and Mergers:
LIST OF TABLES
- TABLE 1 LAMEA Renal Denervation Market, 2018 - 2021, USD Thousands
- TABLE 2 LAMEA Renal Denervation Market, 2022 - 2028, USD Thousands
- TABLE 3 LAMEA Renal Denervation Market by Technology, 2018 - 2021, USD Thousands
- TABLE 4 LAMEA Renal Denervation Market by Technology, 2022 - 2028, USD Thousands
- TABLE 5 LAMEA Radiofrequency Market by Country, 2018 - 2021, USD Thousands
- TABLE 6 LAMEA Radiofrequency Market by Country, 2022 - 2028, USD Thousands
- TABLE 7 LAMEA Ultrasound Market by Country, 2018 - 2021, USD Thousands
- TABLE 8 LAMEA Ultrasound Market by Country, 2022 - 2028, USD Thousands
- TABLE 9 LAMEA Micro-Infusion Market by Country, 2018 - 2021, USD Thousands
- TABLE 10 LAMEA Micro-Infusion Market by Country, 2022 - 2028, USD Thousands
- TABLE 11 LAMEA Renal Denervation Market by End User, 2018 - 2021, USD Thousands
- TABLE 12 LAMEA Renal Denervation Market by End User, 2022 - 2028, USD Thousands
- TABLE 13 LAMEA Hospitals Market by Country, 2018 - 2021, USD Thousands
- TABLE 14 LAMEA Hospitals Market by Country, 2022 - 2028, USD Thousands
- TABLE 15 LAMEA Specialty Clinics Market by Country, 2018 - 2021, USD Thousands
- TABLE 16 LAMEA Specialty Clinics Market by Country, 2022 - 2028, USD Thousands
- TABLE 17 LAMEA Others Market by Country, 2018 - 2021, USD Thousands
- TABLE 18 LAMEA Others Market by Country, 2022 - 2028, USD Thousands
- TABLE 19 LAMEA Renal Denervation Market by Product Type, 2018 - 2021, USD Thousands
- TABLE 20 LAMEA Renal Denervation Market by Product Type, 2022 - 2028, USD Thousands
- TABLE 21 LAMEA Symplicity Market by Country, 2018 - 2021, USD Thousands
- TABLE 22 LAMEA Symplicity Market by Country, 2022 - 2028, USD Thousands
- TABLE 23 LAMEA Enlightn Market by Country, 2018 - 2021, USD Thousands
- TABLE 24 LAMEA Enlightn Market by Country, 2022 - 2028, USD Thousands
- TABLE 25 LAMEA Vessix Market by Country, 2018 - 2021, USD Thousands
- TABLE 26 LAMEA Vessix Market by Country, 2022 - 2028, USD Thousands
- TABLE 27 LAMEA Paradise Market by Country, 2018 - 2021, USD Thousands
- TABLE 28 LAMEA Paradise Market by Country, 2022 - 2028, USD Thousands
- TABLE 29 LAMEA Iberis Market by Country, 2018 - 2021, USD Thousands
- TABLE 30 LAMEA Iberis Market by Country, 2022 - 2028, USD Thousands
- TABLE 31 LAMEA Others Market by Country, 2018 - 2021, USD Thousands
- TABLE 32 LAMEA Others Market by Country, 2022 - 2028, USD Thousands
- TABLE 33 LAMEA Renal Denervation Market by Country, 2018 - 2021, USD Thousands
- TABLE 34 LAMEA Renal Denervation Market by Country, 2022 - 2028, USD Thousands
- TABLE 35 Brazil Renal Denervation Market, 2018 - 2021, USD Thousands
- TABLE 36 Brazil Renal Denervation Market, 2022 - 2028, USD Thousands
- TABLE 37 Brazil Renal Denervation Market by Technology, 2018 - 2021, USD Thousands
- TABLE 38 Brazil Renal Denervation Market by Technology, 2022 - 2028, USD Thousands
- TABLE 39 Brazil Renal Denervation Market by End User, 2018 - 2021, USD Thousands
- TABLE 40 Brazil Renal Denervation Market by End User, 2022 - 2028, USD Thousands
- TABLE 41 Brazil Renal Denervation Market by Product Type, 2018 - 2021, USD Thousands
- TABLE 42 Brazil Renal Denervation Market by Product Type, 2022 - 2028, USD Thousands
- TABLE 43 Argentina Renal Denervation Market, 2018 - 2021, USD Thousands
- TABLE 44 Argentina Renal Denervation Market, 2022 - 2028, USD Thousands
- TABLE 45 Argentina Renal Denervation Market by Technology, 2018 - 2021, USD Thousands
- TABLE 46 Argentina Renal Denervation Market by Technology, 2022 - 2028, USD Thousands
- TABLE 47 Argentina Renal Denervation Market by End User, 2018 - 2021, USD Thousands
- TABLE 48 Argentina Renal Denervation Market by End User, 2022 - 2028, USD Thousands
- TABLE 49 Argentina Renal Denervation Market by Product Type, 2018 - 2021, USD Thousands
- TABLE 50 Argentina Renal Denervation Market by Product Type, 2022 - 2028, USD Thousands
- TABLE 51 UAE Renal Denervation Market, 2018 - 2021, USD Thousands
- TABLE 52 UAE Renal Denervation Market, 2022 - 2028, USD Thousands
- TABLE 53 UAE Renal Denervation Market by Technology, 2018 - 2021, USD Thousands
- TABLE 54 UAE Renal Denervation Market by Technology, 2022 - 2028, USD Thousands
- TABLE 55 UAE Renal Denervation Market by End User, 2018 - 2021, USD Thousands
- TABLE 56 UAE Renal Denervation Market by End User, 2022 - 2028, USD Thousands
- TABLE 57 UAE Renal Denervation Market by Product Type, 2018 - 2021, USD Thousands
- TABLE 58 UAE Renal Denervation Market by Product Type, 2022 - 2028, USD Thousands
- TABLE 59 Saudi Arabia Renal Denervation Market, 2018 - 2021, USD Thousands
- TABLE 60 Saudi Arabia Renal Denervation Market, 2022 - 2028, USD Thousands
- TABLE 61 Saudi Arabia Renal Denervation Market by Technology, 2018 - 2021, USD Thousands
- TABLE 62 Saudi Arabia Renal Denervation Market by Technology, 2022 - 2028, USD Thousands
- TABLE 63 Saudi Arabia Renal Denervation Market by End User, 2018 - 2021, USD Thousands
- TABLE 64 Saudi Arabia Renal Denervation Market by End User, 2022 - 2028, USD Thousands
- TABLE 65 Saudi Arabia Renal Denervation Market by Product Type, 2018 - 2021, USD Thousands
- TABLE 66 Saudi Arabia Renal Denervation Market by Product Type, 2022 - 2028, USD Thousands
- TABLE 67 South Africa Renal Denervation Market, 2018 - 2021, USD Thousands
- TABLE 68 South Africa Renal Denervation Market, 2022 - 2028, USD Thousands
- TABLE 69 South Africa Renal Denervation Market by Technology, 2018 - 2021, USD Thousands
- TABLE 70 South Africa Renal Denervation Market by Technology, 2022 - 2028, USD Thousands
- TABLE 71 South Africa Renal Denervation Market by End User, 2018 - 2021, USD Thousands
- TABLE 72 South Africa Renal Denervation Market by End User, 2022 - 2028, USD Thousands
- TABLE 73 South Africa Renal Denervation Market by Product Type, 2018 - 2021, USD Thousands
- TABLE 74 South Africa Renal Denervation Market by Product Type, 2022 - 2028, USD Thousands
- TABLE 75 Nigeria Renal Denervation Market, 2018 - 2021, USD Thousands
- TABLE 76 Nigeria Renal Denervation Market, 2022 - 2028, USD Thousands
- TABLE 77 Nigeria Renal Denervation Market by Technology, 2018 - 2021, USD Thousands
- TABLE 78 Nigeria Renal Denervation Market by Technology, 2022 - 2028, USD Thousands
- TABLE 79 Nigeria Renal Denervation Market by End User, 2018 - 2021, USD Thousands
- TABLE 80 Nigeria Renal Denervation Market by End User, 2022 - 2028, USD Thousands
- TABLE 81 Nigeria Renal Denervation Market by Product Type, 2018 - 2021, USD Thousands
- TABLE 82 Nigeria Renal Denervation Market by Product Type, 2022 - 2028, USD Thousands
- TABLE 83 Rest of LAMEA Renal Denervation Market, 2018 - 2021, USD Thousands
- TABLE 84 Rest of LAMEA Renal Denervation Market, 2022 - 2028, USD Thousands
- TABLE 85 Rest of LAMEA Renal Denervation Market by Technology, 2018 - 2021, USD Thousands
- TABLE 86 Rest of LAMEA Renal Denervation Market by Technology, 2022 - 2028, USD Thousands
- TABLE 87 Rest of LAMEA Renal Denervation Market by End User, 2018 - 2021, USD Thousands
- TABLE 88 Rest of LAMEA Renal Denervation Market by End User, 2022 - 2028, USD Thousands
- TABLE 89 Rest of LAMEA Renal Denervation Market by Product Type, 2018 - 2021, USD Thousands
- TABLE 90 Rest of LAMEA Renal Denervation Market by Product Type, 2022 - 2028, USD Thousands
- TABLE 91 Key Information - Abbott Laboratories
- TABLE 92 key Information - Boston Scientific Corporation
- TABLE 93 Key Information - Medtronic PLC
- TABLE 94 Key Information - Ablative Solutions, Inc.
- TABLE 95 Key Information - Mercator MedSystems, Inc.
- TABLE 96 Key Information - ReCor Medical, Inc
- TABLE 97 Key Information - Renal Dynamics Limited
- TABLE 98 Key information - Johnson & Johnson
- TABLE 99 Key Information - Terumo Corporation
List of Figures
- FIG 1 Methodology for the research
